AbbVie Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
101
- Portfolio
-
37
- Exits
-
41
AbbVie Ventures General Information
Company Description
Founded in 2009, AbbVie Ventures is the corporate venture arm of AbbVie, based in Cambridge, Massachusetts. The firm prefers to invest in the oncology, immunology, neuroscience, eye care, and aesthetics sectors.
Business Details
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 139 Main Street
- 2nd Floor
- Cambridge, MA 02142
- United States
AbbVie Ventures Investments (101)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| PsiThera | 10-Nov-2026 | Early Stage VC | Drug Discovery | Startup | ||
| Cloverleaf Bio | 08-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Quanta Therapeutics | 24-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Third Arc Bio | 12-Jan-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| DISCO Pharmaceuticals | 11-Dec-2025 | Drug Discovery | Generating Revenue | |||
| Zag Bio | 25-Oct-2025 | Drug Delivery | Startup | |||
| Soufflé Therapeutics | 07-Oct-2025 | Therapeutic Devices | Pre-Clinical Trials | |||
| Cephagenix | 10-Sep-2025 | Drug Discovery | Generating Revenue | |||
| DaCapo Brainscience | 01-Jun-2025 | Seed Round | Drug Discovery | Startup | ||
| Syndeio Biosciences | 27-May-2025 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
AbbVie Ventures Exits (41)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| AM-Pharma | 20-Oct-2026 | Merger/Acquisition | |
| Faze Medicines | 12-Oct-2025 | ||
| Gate Neurosciences | 27-May-2025 | ||
| Sionna Therapeutics | 06-Feb-2025 | ||
| Jnana Therapeutics | 08-Oct-2024 | ||
| Ribon Therapeutics | 05-Aug-2024 | ||
| Caraway Therapeutics | 20-Nov-2023 | ||
| PACT Pharma | 29-Sep-2023 | ||
| Carisma Therapeutics | 07-Mar-2023 | Reverse Merger | |
| Disc Medicine | 30-Dec-2022 | Reverse Merger |
AbbVie Ventures Investments by Industry, Year, and Region
AbbVie Ventures Co-Investors (125)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Vida Ventures (Los Angeles) | 3 |
|
|
||
| Atlas Venture |
|
|
|||
| Bristol-Myers Squibb |
|
|
|||
| Sofinnova Partners |
|
|
|||
| T. Rowe Price Group |
|
|
AbbVie Ventures FAQs
-
What is AbbVie Ventures?
Founded in 2009, AbbVie Ventures is the corporate venture arm of AbbVie, based in Cambridge, Massachusetts.
-
When was AbbVie Ventures founded?
AbbVie Ventures was founded in 2009.
-
Where is AbbVie Ventures headquartered?
AbbVie Ventures is headquartered in Cambridge, MA.
-
How many investments has AbbVie Ventures made?
AbbVie Ventures has made 101 investments.
-
What has AbbVie Ventures invested in?
AbbVie Ventures has made numerous investments in companies like PsiThera, Cloverleaf Bio, and Quanta Therapeutics within the Drug Discovery industry.
-
What has AbbVie Ventures invested in recently?
AbbVie Ventures's latest investment was on 10-Nov-2026 in PsiThera, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process